Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate

Reduced bone mineral density (BMD) is common in long-term renal transplant recipients and results in a high incidence of fractures. The optimal therapy for these patients is not known. Baseline BMD determinations were obtained in 211 long-term adult renal transplant recipients. One hundred and seven...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2003-11, Vol.76 (10), p.1498-1502
Hauptverfasser:	JEFFERY, John R, LESLIE, William D, KARPINSKI, Martin E, NICKERSON, Peter W, RUSH, David N
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alendronate - therapeutic use Azathioprine - therapeutic use Biological and medical sciences Bone Density - drug effects Bone Resorption - drug therapy Bone Resorption - etiology Bone Resorption - prevention & control Calcitriol - therapeutic use Calcium Channel Agonists - therapeutic use Combined surgery. Multiple transplantations Cross-Sectional Studies Cyclosporine - therapeutic use Female Humans Immunosuppression - methods Kidney Transplantation - adverse effects Male Medical sciences Middle Aged Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Postoperative Complications - drug therapy Postoperative Complications - prevention & control Prednisone - therapeutic use Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!